Metabolic Syndrome May Affect Survival in Postmenopausal Women With Triple-Negative Breast Cancer
Researchers analyzed the association between baseline metabolic syndrome components and survival outcomes in women diagnosed with TNBC.
Headlines
High Use of Oncology Nurse Navigators Showed Similar Clinical Outcomes for White, Nonwhite Patients With DLBCL
Although previous population-based studies have shown worse clinical outcomes for minority patients with DLBCL compared with white patients, this study reported no differences in PFS and OS were seen between the 2 groups.
Bridging Therapy Prior to CAR-T Is Not Recommended for All Patients With Lymphoma
Researchers noted that bridging while awaiting CAR-T manufacturing may not be appropriate for all patients, and in some cases, bridging was associated with worse PFS and OS.
Treatment With PI3K Inhibitors Is Associated With a Number of Adverse Events and Toxicities
Despite improved survival in patients with B cell malignancies who are treated with PI3K inhibitors, researchers found incidences of pneumonitis, infections, and sepsis are higher in these patients.
Cumulative Illness Rating Scale Has Prognostic Significance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Researchers found that CIRS scores are prognostic for overall and progression-free survival in patients with R/R DLBCL being evaluated for CAR-T therapy.
Acute Myeloid Leukemia Survivors at Greater Risk of Long-Term Morbidity After BMT Compared With Healthy Siblings
AML survivors treated with blood or marrow transplantation have a greater risk of grade 3 or higher chronic health conditions, according to a survey that compared the long-term outcomes between survivors and their healthy siblings.
Many Young Adult Hematopoietic Cell Transplant Survivors May Need Return-to-Work Interventions Post Transplant
Data from the CIBMTR demonstrate a need to develop return-to-work interventions for patients who have undergone HCT as treatment of malignant, as well as nonmalignant, conditions.
Monitoring Disease Recurrence With Patient-Reported Outcomes After Discontinuation of Tyrosine Kinase Inhibitor Therapy
Results of LAST, the largest study on TKI discontinuation, support using patient-reported outcomes when monitoring remission and symptoms in patients who discontinue TKI therapy.
Assessing VTE Risk Based on Presence of Elevated Biomarkers Provides Better Risk Stratification Than Current Methods
New scoring method provides a more nuanced risk stratification of VTE than the Khorana score in ambulatory patients with cancer.
Analysis Links Presence of S Aureas and Cutaneous T-Cell Lymphoma Progression
Using culture analysis and sequencing analysis, researchers found a correlation between CTCL and the presence of S aureus in patients’ skin flora.
Want to read more?
Please login or register first to view this content.
Next post in ASH 2019
